Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity. | Lancet;399(10331): 1223-1224, 2022 03 26. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity.

Núñez, Isaac.

Núñez I; Department of Medical Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico. Electronic address: isaac.nunezs@incmnsz.mx.

Lancet ; 399(10331): 1223-1224, 2022 03 26.

Article in English | MEDLINE | ID: covidwho-1815312

Subject(s)

Health Equity; Vaccines; Drug Approval; Humans; Vaccine Development

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Health Equity Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Health Equity Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article